Alopecia areata (AA) is a relatively common nonscarring hairloss disease characterized by
an autoimmune response to anagen hair follicles (HFs). Accumulated evidence suggests …

Alopecia areata (AA) is an autoimmune disease that presents as nonscarring hair loss,
although the exact pathogenesis of the disease remains to be clarified. Disease prevalence …

Alopecia areata (AA) is a chronic, immune‐mediated disease characterized by acute or
chronic non‐scarring hair loss, with a heterogeneity in clinical manifestations ranging from …

Various therapeutic agents have been described for the treatment of alopecia areata (AA),
but none are curative or preventive. The aim of AA treatment is to suppress the activity of the …

Background There is a lack of population‐based information on the disease burden and
management of alopecia areata (AA). Objectives To describe the epidemiology of AA …

Background Unmet needs exist in actinic keratosis (AK) treatment. Daylight photodynamic
therapy (DL‐PDT) has shown good efficacy and safety results compared to conventional …

Background Alopecia areata is a disorder in which there is loss of hair causing patches of
baldness but with no scarring of the affected area. It can affect the entire scalp (alopecia …

Objective To provide family physicians with a background understanding of the
epidemiology, pathogenesis, histology, and clinical approach to the diagnosis of alopecia …

Foaming of cleaning agents in the household is an effect which is not connected with the
quality of cleaning process. Foam development of some cosmetic formulations such as hair …

Alopecia areata (AA) is a common nonscarring hair condition responsible for 0.7% to 3.8%
of dermatology clinics visits. 1 The lifetime risk in the United States was estimated at 1.7%. 2 …